Psychiatry and Neurology, Neurology · Hackensack, NJ
NPI
1851331680
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
381 Park St., Suite 200
Hackensack, NJ, 07601
Phone (201) 546-8510
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
827 services
Medicare patients, 2024
351
Average age 70
Drug cost, 2024
$1.1M
2,103 prescriptions
Company payments, 2025
$1,999
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Georges A Ghacibeh was code 99214 (office e&m - established), 179 times for 113 patients. In total Georges A Ghacibeh billed 827 services in 31 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 179 | 113 | $86.19 | $15K |
| 95720 Neurologic | Facility | 130 | 71 | $175.54 | $23K |
| 99215 Office E&M - Established | Office | 78 | 70 | $133.09 | $10K |
| 95718 Neurologic | Facility | 47 | 39 | $115.14 | $5,412 |
| 99232 Hospital E&M - Subsequent | Facility | 44 | 27 | $67.57 | $2,973 |
| 95715 Neurologic | Office | 41 | 20 | $848.46 | $35K |
| 99291 Critical Care E&M | Facility | 40 | 17 | $171.63 | $6,865 |
| 95800 Sleep Study | Facility | 39 | 39 | $34.27 | $1,337 |
| 99223 Hospital E&M - Initial | Facility | 30 | 30 | $148.33 | $4,450 |
| 95700 Neurologic | Office | 26 | 22 | $203.66 | $5,295 |
| 99205 Office E&M - New | Office | 23 | 23 | $155.49 | $3,576 |
| 99233 Hospital E&M - Subsequent | Facility | 19 | 13 | $101.83 | $1,935 |
| 95810 Sleep Study | Facility | 19 | 19 | $105.39 | $2,002 |
| 95811 Sleep Study | Facility | 15 | 15 | $102.28 | $1,534 |
| 95722 Neurologic | Office | 15 | 14 | $223.00 | $3,345 |
By year: 2022 $106K for 592 services; 2023 $90K for 564 services; 2024 $133K for 827 services.
Medicare prescription drug claims, 2024
In 2024, the drug Georges A Ghacibeh prescribed most often to Medicare patients was Lamotrigine, with 125 prescriptions and refills. In total Georges A Ghacibeh wrote 2,103 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 125 | 238 | 25 | $3,133 |
| Clonazepam Generic | 94 | 122 | 15 | $1,810 |
| Levetiracetam Generic | 90 | 155 | 21 | $4,214 |
| Divalproex Sodium Generic | 79 | 96 | Under 11 | $5,018 |
| Lacosamide Generic | 73 | 103 | 15 | $24K |
| Mirtazapine Generic | 67 | 122 | 17 | $1,444 |
| Clobazam Generic | 65 | 92 | 11 | $14K |
| Xcopri Cenobamate | 65 | 66 | Under 11 | $83K |
| Briviact Brivaracetam | 61 | 61 | Under 11 | $98K |
| Donepezil Hcl Generic | 59 | 119 | 15 | $744 |
| Topiramate Generic | 58 | 109 | 11 | $1,145 |
| Pregabalin Generic | 55 | 81 | 19 | $1,000 |
| Sertraline Hcl Generic | 52 | 71 | Under 11 | $312 |
| Quetiapine Fumarate Generic | 49 | 81 | Under 11 | $719 |
| Gabapentin Generic | 47 | 119 | 19 | $666 |
Brand drugs: - claims; generic drugs: 1,699 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Georges A Ghacibeh $1,999 ($1,999 in general payments such as food, travel and fees) from 15 companies. The largest payer was UCB, Inc. with $1,089.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 9 | $1,089 |
| Avadel CNS Pharmaceuticals, LLC | 11 | $328 |
| Inspire Medical Systems, Inc. INSP | 2 | $161 |
| Harmony Biosciences LLC HRMY | 4 | $108 |
| SK Life Science, Inc. | 4 | $69.83 |
| Supernus Pharmaceuticals, Inc. SUPN | 2 | $39.56 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $34.24 |
| Neurelis, Inc. | 2 | $33.36 |
| Otter Pharmaceuticals, LLC | 2 | $28.53 |
| Aucta Pharmaceuticals, Inc. | 2 | $28.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.